Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies

Although classical Hodgkin lymphoma (cHL) is usually curable, 20–30% of the patients experience treatment failure and most of them are typically treated with salvage chemotherapy and autologous stem cell transplantation (autoSCT). However, 45–55% of that subset further relapse or progress despite in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Vassilakopoulos, Theodoros P., Chatzidimitriou, Chrysovalantou, Asimakopoulos, John V., Arapaki, Maria, Tzoras, Evangelos, Angelopoulou, Maria K., Konstantopoulos, Kostas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2019
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721364/
https://ncbi.nlm.nih.gov/pubmed/31362369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081071
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller